UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16318) 16318
Newsletter (53) 53
Newspaper Article (49) 49
Publication (8) 8
Book / eBook (5) 5
Magazine Article (4) 4
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15226) 15226
science & technology (12485) 12485
life sciences & biomedicine (11090) 11090
female (8936) 8936
male (8858) 8858
middle aged (7704) 7704
oncology (6826) 6826
aged (6801) 6801
tumors (6470) 6470
biological and medical sciences (6355) 6355
medical sciences (6248) 6248
stomach neoplasms - pathology (5220) 5220
stomach cancer (5173) 5173
adult (5158) 5158
cancer (5139) 5139
gastroenterology. liver. pancreas. abdomen (5064) 5064
stomach. duodenum. small intestine. colon. rectum. anus (4943) 4943
gastric cancer (4377) 4377
gastroenterology & hepatology (3144) 3144
stomach neoplasms - immunology (3106) 3106
prognosis (2915) 2915
medicine & public health (2750) 2750
aged, 80 and over (2719) 2719
surgery (2646) 2646
stomach neoplasms - genetics (2301) 2301
animals (2300) 2300
gastroenterology (2220) 2220
immunohistochemistry (2138) 2138
analysis (2121) 2121
colorectal cancer (1965) 1965
research (1918) 1918
stomach neoplasms - surgery (1898) 1898
neoplasm staging (1837) 1837
pathology (1832) 1832
metastasis (1824) 1824
stomach neoplasms - metabolism (1691) 1691
risk factors (1671) 1671
medicine (1664) 1664
research article (1655) 1655
cell line, tumor (1647) 1647
mice (1518) 1518
health aspects (1428) 1428
science & technology - other topics (1398) 1398
multidisciplinary sciences (1388) 1388
cancer research (1387) 1387
gene expression (1373) 1373
surgical oncology (1362) 1362
adenocarcinoma - pathology (1351) 1351
chemotherapy (1349) 1349
abridged index medicus (1340) 1340
treatment outcome (1321) 1321
retrospective studies (1316) 1316
stomach neoplasms - drug therapy (1300) 1300
science (1294) 1294
care and treatment (1263) 1263
genetic aspects (1256) 1256
stomach neoplasms - mortality (1227) 1227
immunology (1219) 1219
abdominal surgery (1218) 1218
helicobacter pylori (1144) 1144
medical prognosis (1125) 1125
proteins (1121) 1121
colorectal neoplasms - pathology (1103) 1103
gene expression regulation, neoplastic (1079) 1079
patients (1032) 1032
oncology, experimental (1016) 1016
follow-up studies (1001) 1001
development and progression (968) 968
apoptosis (960) 960
survival rate (950) 950
lymphatic metastasis (948) 948
stomach neoplasms - diagnosis (943) 943
survival analysis (918) 918
stomach neoplasms - microbiology (901) 901
case-control studies (889) 889
studies (866) 866
gastrectomy (850) 850
hepatology (841) 841
antineoplastic agents (789) 789
metastases (773) 773
cell biology (763) 763
stomach (758) 758
internal medicine (752) 752
multivariate analysis (750) 750
adenocarcinoma - immunology (743) 743
cell proliferation (735) 735
genes (735) 735
stomach neoplasms - therapy (735) 735
medical research (731) 731
pharmacology. drug treatments (729) 729
colonic neoplasms - immunology (724) 724
mutation (721) 721
neoplasm invasiveness (714) 714
cancer therapies (706) 706
helicobacter infections - complications (695) 695
biomarkers (688) 688
gastric mucosa - pathology (688) 688
cancers and neoplasms (687) 687
prospective studies (687) 687
diagnosis (676) 676
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15682) 15682
Japanese (859) 859
Chinese (235) 235
Russian (232) 232
German (67) 67
French (51) 51
Spanish (37) 37
Polish (35) 35
Italian (34) 34
Portuguese (10) 10
Croatian (4) 4
Czech (4) 4
Korean (4) 4
Romanian (4) 4
Hungarian (3) 3
Bulgarian (2) 2
Danish (2) 2
Dutch (2) 2
Finnish (2) 2
Swedish (2) 2
Slovenian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of clinical investigation, ISSN 0021-9738, 08/2017, Volume 127, Issue 8, pp. 2930 - 2940
Journal Article
Cancer science, ISSN 1347-9032, 07/2016, Volume 107, Issue 7, pp. 1039 - 1046
topoisomerase I inhibitor | T‐DM | HER2 | bystander killing | Antibody‐drug conjugate | T-DM | Antibody-drug conjugate | Life Sciences & Biomedicine | Oncology | Science & Technology | Receptor, ErbB-2 - genetics | Breast Neoplasms - immunology | Humans | Ado-Trastuzumab Emtansine | Stomach Neoplasms - pathology | Maytansine - pharmacology | Immunoconjugates - immunology | Breast Neoplasms - enzymology | Immunoconjugates - pharmacology | Topoisomerase I Inhibitors - pharmacology | Neoplasms - genetics | Antibodies, Monoclonal, Humanized - pharmacology | Female | Camptothecin - immunology | Receptor, ErbB-2 - immunology | Camptothecin - analogs & derivatives | Stomach Neoplasms - enzymology | Stomach Neoplasms - genetics | Maytansine - analogs & derivatives | Neoplasms - enzymology | Stomach Neoplasms - immunology | Animals | Breast Neoplasms - genetics | Bystander Effect - drug effects | Breast Neoplasms - pathology | Mice, Nude | Neoplasms - immunology | Cell Membrane Permeability - drug effects | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | Antibodies, Monoclonal, Humanized - immunology | Neoplasms - pathology | Camptothecin - pharmacology | Maytansine - immunology | Trastuzumab | Viral antibodies | Epidermal growth factor | Imaging systems | Antibodies | Permeability | Drug therapy | Biopharmaceutics | Tumors | Antigens | Hematology | Laboratories | Toxicity | DNA topoisomerase | Polymerization | Clinical trials | Cytotoxicity | Breast cancer | ErbB-2 protein | Stomach cancer | Lymphoma | Hypotheses | Antitumor agents | Xenografts | Antitumor activity | Drug dosages | Payloads | Index Medicus | Original
Journal Article
Clinical immunology (Orlando, Fla.), ISSN 1521-6616, 2016, Volume 166-167, pp. 48 - 58
Allergy and Immunology | Translational research | Five-peptide cancer vaccine | Cyclophosphamide | Regulatory T cells | Life Sciences & Biomedicine | Immunology | Science & Technology | Lung Neoplasms - drug therapy | Cyclophosphamide - administration & dosage | Colorectal Neoplasms - genetics | Humans | Middle Aged | HLA-A24 Antigen - genetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epitopes - administration & dosage | Male | Cyclophosphamide - adverse effects | Peptides - administration & dosage | Dose-Response Relationship, Drug | Epitopes - immunology | Neoplasms - genetics | T-Lymphocytes - metabolism | T-Lymphocytes - drug effects | Colorectal Neoplasms - drug therapy | Leukopenia - chemically induced | Aged, 80 and over | Adult | Female | Vaccines, Subunit - adverse effects | Lung Neoplasms - genetics | Stomach Neoplasms - genetics | HLA-A24 Antigen - immunology | Drug Administration Schedule | Cancer Vaccines - administration & dosage | Peptides - immunology | Kaplan-Meier Estimate | Cancer Vaccines - adverse effects | Treatment Outcome | Cyclophosphamide - immunology | Vaccines, Subunit - immunology | Stomach Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - immunology | Neoplasms - drug therapy | Stomach Neoplasms - immunology | Cancer Vaccines - immunology | Lung Neoplasms - immunology | Colorectal Neoplasms - immunology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms - immunology | Vaccines, Subunit - administration & dosage | T-Lymphocytes - immunology | Aged | Cancer vaccines | Antigens | Chemotherapy | Peptides | Vaccination | Colorectal cancer | Clinical trials | Product development | T cells | Cancer | Tumors | Index Medicus
Journal Article
Journal Article
Gastric Cancer, ISSN 1436-3291, 1/2017, Volume 20, Issue 1, pp. 156 - 163
Chemotherapy | Prognosis | Medicine & Public Health | Mismatch repair | Gastroenterology | Abdominal Surgery | Oncology | Cancer Research | Microsatellite instability | Surgical Oncology | Gastric cancer | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Lung Neoplasms - drug therapy | Microsatellite Instability | Follow-Up Studies | Humans | Male | Stomach Neoplasms - pathology | DNA Mismatch Repair - genetics | Cisplatin - administration & dosage | Organoplatinum Compounds - administration & dosage | Peritoneal Neoplasms - drug therapy | Fluorouracil - administration & dosage | Lung Neoplasms - secondary | Female | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Liver Neoplasms - secondary | Peritoneal Neoplasms - immunology | Neutrophils - pathology | Peritoneal Neoplasms - secondary | Lung Neoplasms - genetics | Stomach Neoplasms - genetics | Liver Neoplasms - genetics | Biomarkers, Tumor - analysis | Liver Neoplasms - drug therapy | Liver Neoplasms - immunology | Survival Rate | Combined Modality Therapy | Stomach Neoplasms - drug therapy | Stomach Neoplasms - immunology | Lung Neoplasms - immunology | Lymphocytes - pathology | Lymphocytes, Tumor-Infiltrating - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Peritoneal Neoplasms - genetics | Aged | Neoplasm Staging | Lymphocytes, Tumor-Infiltrating - immunology | Cancer patients | Care and treatment | Immune response | Patient outcomes | Immunotherapy | Metastasis | Stomach cancer | Cancer | Index Medicus
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 10/2011, Volume 60, Issue 10, pp. 1419 - 1430
Journal Article